Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 4
1977 4
1978 2
1979 1
1980 5
1981 5
1982 3
1984 1
1985 2
1986 2
1987 3
1988 6
1990 3
1991 2
1992 5
1993 4
1994 9
1995 15
1996 3
1997 4
1998 8
1999 8
2000 8
2001 7
2002 9
2003 12
2004 10
2005 16
2006 9
2007 13
2008 9
2009 11
2010 9
2011 12
2012 8
2013 21
2014 15
2015 7
2016 2
2017 4
2018 5
2019 7
2020 7
2021 5
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
Immunopathogenesis of sarcoidosis and risk of malignancy: a lost truth?
Tana C, Giamberardino MA, Di Gioacchino M, Mezzetti A, Schiavone C. Tana C, et al. Among authors: mezzetti a. Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):305-13. doi: 10.1177/039463201302600204. Int J Immunopathol Pharmacol. 2013. PMID: 23755746 Free article. Review.
White-coat resistant hypertension.
Mezzetti A, Pierdomenico SD, Costantini F, Romano F, Bucci A, Di Gioacchino M, Cuccurullo F. Mezzetti A, et al. Am J Hypertens. 1997 Nov;10(11):1302-7. doi: 10.1016/s0895-7061(97)00318-x. Am J Hypertens. 1997. PMID: 9397251 Clinical Trial.
COX-2: friend or foe?
Iezzi A, Ferri C, Mezzetti A, Cipollone F. Iezzi A, et al. Among authors: mezzetti a. Curr Pharm Des. 2007;13(16):1715-21. doi: 10.2174/138161207780831293. Curr Pharm Des. 2007. PMID: 17584101 Review.
300 results